Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : ADVR:THE NEW COMPANY...WITH A NEW LIFE...AND A NEW MISSION -- Ignore unavailable to you. Want to Upgrade?

To: OLD JAKE JUSTUS who wrote (4682)	12/15/1999 8:56:00 AM
From: Kingfisher	Read Replies (1) \| Respond to of 4891

Jake, I feel that there is still time to participate in this stock. We ate still within the time-window set by Dr. Hirschman to meet his objectives in making ADVR a viable company. Also, I feel that his decision to re-name Reticulose as Substance R and call it a NEW DRUG may be the best way to get investors to listen and realize that this drug has EFFICACY in treatment, is NON-TOXIC and REGULATES THE IMMUNE SYSTEM to help the body overcome effects caused by viruses. These are characteristics that you and I,and a lot of us, have known and understood about Reticulose for years.